NTRK Fusion-positive Non–small-cell Lung Cancer: The Diagnosis and Targeted Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NTRK Fusion-positive Non–small-cell Lung Cancer: The Diagnosis and Targeted Therapy

Published:2021-01 Issue:1 Volume:22 Page:1-5
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Haratake Naoki,Seto Takashi

Funder

Bayer Yakuhin

Eisai

Merck Serono

Novartis Pharma

Astellas Pharma

AstraZeneca

Chugai Pharmaceutical

Daiichi-Sankyo

Eli Lilly Japan

Kissei Pharmaceutical

MSD

Nippon Boehringer Ingelheim

Pfizer Japan

Yakult Honsha

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

3. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol,2011

5. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N Engl J Med,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives;International Journal of Cancer;2024-07-03

2. Testing for genomic biomarkers in non-small-cell lung cancer;Diagnostic Histopathology;2024-07

3. Molecular Mechanisms and Potential Predictive Biomarkers in Advanced Non-small Cell Lung Cancer: A Summary of Current and Future Trends;Archives of Surgery and Clinical Research;2024-06-27

4. Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer;Frontiers in Oncology;2024-06-18

5. Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data;Translational Lung Cancer Research;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3